Giani E, Scaramuzza AE, Zuccotti GV. Impact of new technologies on diabetes care. World J Diabetes 2015; 6(8): 999-1004 [PMID: 26240696 DOI: 10.4239/wjd.v6.i8.999]
Corresponding Author of This Article
Gian Vincenzo Zuccotti, MD, Full Professor and Chairman, Department of Pediatrics, Ospedale dei Bambini-V. Buzzi, Università degli Studi di Milano, 32, Via Castelvetro, 20154 Milan, Italy. gianvincenzo.zuccotti@unimi.it
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Jul 25, 2015; 6(8): 999-1004 Published online Jul 25, 2015. doi: 10.4239/wjd.v6.i8.999
Impact of new technologies on diabetes care
Elisa Giani, Andrea Enzo Scaramuzza, Gian Vincenzo Zuccotti
Elisa Giani, Gian Vincenzo Zuccotti, Department of Pediatrics, Ospedale dei Bambini-V. Buzzi, Università degli Studi di Milano, 20154 Milan, Italy
Andrea Enzo Scaramuzza, Department of Pediatrics, Ospedale L. Sacco, 20157 Milan, Italy
Gian Vincenzo Zuccotti, Center for Research in Nutrition (CURN), Biomedical and Clinical Science Department, Università degli Studi di Milano, 20154 Milan, Italy
Author contributions: Giani E, Scaramuzza AE and Zuccotti GV developed the theme idea and performed the work, drafted the manuscript, discussed the manuscript and approved the final version of the manuscript.
Conflict-of-interest statement: The authors declare that there is no conflict of interest related to the present paper.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Gian Vincenzo Zuccotti, MD, Full Professor and Chairman, Department of Pediatrics, Ospedale dei Bambini-V. Buzzi, Università degli Studi di Milano, 32, Via Castelvetro, 20154 Milan, Italy. gianvincenzo.zuccotti@unimi.it
Telephone: +39-02-57995322 Fax: +39-02-57995132
Received: January 26, 2015 Peer-review started: January 28, 2015 First decision: May 14, 2015 Revised: May 31, 2015 Accepted: June 30, 2015 Article in press: July 2, 2015 Published online: July 25, 2015
Core Tip
Core tip: There have been many advances in the technologies associated with diabetes care in the last few years, which have resulted in new opportunities in the treatment of diabetes. Despite the encouraging results and the prospect of a fully automated closed loop system in the near future, metabolic control remains suboptimal in most patients with type 1 diabetes. Data from registries has recently shown that a large proportion of children with type 1 diabetes does not meet the age associated A1c targets across all countries, especially in the youth age. This editorial discusses the impact of these technologies on glycemic control and quality of life and attempts to address how to overcome barriers using these technologies to achieve improved metabolic control.
